Comments

Steris Stock Guidance

STENYSE

Logo brought to you by Benzinga Data

Trade with Public

$254.07

2.280.91%

At close: Dec 15, 4:00 PM EST

$254.07

N/A

After Hours: 4:07 PM EST

Overview News Earnings Options

Guidance

Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Steris Stock Guidance | NYSE:STE | Benzinga

Steris issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
11/05/2025	STE	Steris	FY	2026	$10.15	$10.30	$10.13	—	—	$5.91B	Get Alert
08/06/2025	STE	Steris	FY	2026	$9.90	$10.15	$10.07	—	—	$5.83B	Get Alert
05/14/2025	STE	Steris	FY	2026	$9.90	$10.15	$9.88	$5.79B	$5.84B	$5.79B	Get Alert
02/05/2025	STE	Steris	FY	2025	$9.05	$9.15	$9.06	$5.45B	$5.45B	$5.49B	Get Alert
11/06/2024	STE	Steris	FY	2025	$9.05	$9.25	$9.16	$5.47B	$5.52B	$5.50B	Get Alert
08/06/2024	STE	Steris	FY	2025	$9.05	$9.25	$9.14	$5.47B	$5.52B	$5.49B	Get Alert
05/08/2024	STE	Steris	FY	2025	$9.05	$9.25	$9.33	$5.47B	$5.52B	$5.67B	Get Alert
02/07/2024	STE	Steris	FY	2024	$8.60	$8.70	$8.67	$5.45B	$5.50B	$5.44B	Get Alert
11/07/2023	STE	Steris	FY	2024	$8.60	$8.80	$8.75	$5.40B	$5.45B	$5.44B	Get Alert
08/01/2023	STE	Steris	FY	2024	$8.60	$8.80	$8.68	$5.40B	$5.45B	$5.33B	Get Alert
05/10/2023	STE	Steris	FY	2024	$8.55	$8.75	$8.75	$5.30B	$5.35B	$5.14B	Get Alert
02/08/2023	STE	Steris	FY	2023	$8.00	$8.10	$8.43	$4.86B	$4.86B	$4.94B	Get Alert
11/09/2022	STE	Steris	FY	2023	$8.40	$8.60	$8.49	$4.95B	$4.95B	$4.98B	Get Alert
08/02/2022	STE	Steris	FY	2023	$8.40	$8.60	$8.70	$5.00B	$5.00B	$5.12B	Get Alert
05/11/2022	STE	Steris	FY	2023	$8.55	$8.75	$8.19	—	—	—	Get Alert
02/08/2022	STE	Steris	FY	2022	$7.85	$7.95	$7.73	—	—	—	Get Alert

FAQ

What is the most recent guidance for Steris (STE)?

The most recent guidance for Steris (STE) was reported on November 5, 2025 for the full year 2026. The company provided earnings per share guidance in the range of $10.15 to $10.30, compared to the estimated EPS of $10.13. Additionally, Steris forecasted revenue between $0.00B and $0.00B for the quarter.

Browse guidance and forecast on all stocks.